FOXO4-DRI: A Senolytic Peptide Research Guide
What is FOXO4-DRI?
FOXO4-DRI is a synthetic peptide designed as a research tool in the study of cellular senescence. The name refers to a D-retro-inverso (DRI) version of a fragment of the FOXO4 protein — a modification that improves the peptide’s stability. It belongs to the senolytic class: compounds studied for their ability to selectively remove senescent cells, the dysfunctional cells that accumulate with age and are a recognised contributor to age-related tissue decline. This places FOXO4-DRI firmly in longevity and ageing research.
Studied mechanisms of action
In research models, FOXO4-DRI is investigated for its ability to disrupt the interaction between the FOXO4 protein and the tumour-suppressor protein p53. In senescent cells, FOXO4 is reported to sequester p53 in the nucleus, helping those cells resist programmed cell death. By interfering with this FOXO4-p53 interaction, FOXO4-DRI is studied for its potential to release p53 and selectively trigger apoptosis in senescent cells while leaving healthy cells largely unaffected. This selectivity for senescent cells is the central feature that defines the senolytic research interest in the peptide.
The state of the research
FOXO4-DRI is a relatively young research compound, studied mostly in cell and animal models of ageing and senescence, where the senolytic mechanism has generated significant interest. It has not been established in controlled human studies, and questions of delivery, selectivity and long-term effect remain open. Within the research community it is treated as an exploratory longevity tool and is studied alongside other approaches to senescent-cell clearance. Results remain preclinical.
Handling & storage for research
Supplied as a lyophilised powder. Store sealed vials cold and protected from light; reconstitute with bacteriostatic water for laboratory handling and keep the reconstituted solution refrigerated, using it within the appropriate window. Avoid repeated freeze-thaw cycles and vigorous agitation. Every Aura Labs batch ships with a third-party certificate of analysis confirming identity and purity above 99%.
Why researchers choose Aura Labs
Aura Labs supplies research peptides across Southeast Asia with third-party testing on every batch, a certificate of analysis available for each lot, and discreet, fast regional dispatch. Purity, accurate labelling and reproducible quality are the priorities researchers rely on for consistent results.
Disclaimer
This material is provided for laboratory and research use only. It is not a drug, supplement, cosmetic or food, and is not intended for human or animal consumption or for any diagnostic or therapeutic use. All information here is for educational purposes and describes preclinical research only.
